Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.
Ace Pharmaceuticals is a leading pharmaceutical company in the niche of medical need products, and is based in Zeewolde, the Netherlands. As an independent company, Ace focuses on the development, production and distribution of licensed and unlicensed medicines. With its activities, Ace meets an essential social need: making and keeping scarce medication available for people for whom it is essential. It does so by actively collaborating with relevant stakeholders, including patient associations, doctors and governmental institutions. Since January 2020, Ace has also been supplying pharmaceutical compounding products to pharmacies in the Netherlands through its business unit Ace Compounding.
Oaklins’ debt advisory team in the Netherlands acted as advisor to the consortium and assisted in establishing a financing package aligned with the current business profile and future growth ambitions.
Jan Willem Popma
Director, Ace Pharmaceuticals BV
Talk to the deal team
EP2C Energy has sold a minority stake to iXO PE
EP2C Energy has structured an LBO transaction with iXO Private Equity to finance strong organic and external growth for the company.Learn more
Sale of Global Security Glazing and Dlubak Specialty Glass Corporation to Isoclima Group
Global Security Glazing and Dlubak Specialty Glass Corporation have been acquired by Isoclima Group, a portfolio company of Stirling Square Capital Partners.Learn more
Naxicap Partners acquires Cobham’s slip rings and rotating systems business
Naxicap Partners has acquired Cobham’s slip rings and rotating systems business.Learn more